ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3090 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3090; 2) Community: the network communities that were significantly associated with the response to NSC 3090; 3) Molecule: the relationships between components within communities and NSC 3090; 4) MDR: the compounds that were significantly associated with the NSC 3090.

NSC Compound Enrichment Correlation
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0273093708703115 0.36504449
NSC 732800 methyl 4-[3-chloro-4-(3-chloro-2-methylanilino)-2,5-dioxo-2,5-dihyd ro-1H-1-pyrrolylmethyl]benzoate 0.0273093708703115 0.18435881
NSC 733465 Null 0.0273093708703115 0.20684425
NSC 742410 5- fluoro-2'-deoxyuridyly-(3'->5')-3'-C-ethynylcytosine 0.0273093708703115 0.34200257
NSC 742418 Ethyl, methoxy, prodigisine 0.0273093708703115 0.32157102
NSC 745062 Null 0.0273093708703115 0.40717955
NSC 746701 N-(4-Chlorophenyl)-N-({[2-(4-chlorophenyl)ethyl]amino]carbonothioyl)benzamide 0.0273093708703115 0.10217223
NSC 752461 Null 0.0273093708703115 0.40180178
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.0273093708703115 0.22353795
NSC 756134 GSK1023156A 0.0273093708703115 0.37691189
Total:86  Current:54    [First] [Prev] [Next] [Last]